Anatara Lifesciences Ltd (ASX:ANR)

Anatara Lifesciences Revenue

In the fiscal year ending June 30, 2026, Anatara Lifesciences had annual revenue of 318.40K AUD, down -67.16%. Anatara Lifesciences had revenue of 177.56K in the half year ending December 31, 2025, a decrease of -34.90%.

• Revenue: 318.40K
• Revenue Growth: -67.16%
• P/S Ratio: 8.93
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 2.84M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	318.40K	-651.05K	-67.16%
Jun 30, 2025	969.46K	325.43K	50.53%
Jun 30, 2024	644.03K	-	-
Jun 30, 2023	-	-	-
Jun 30, 2022	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 25, 2026

Data Sources Report a data error